Ozone

( DrugBank: Ozone / KEGG DRUG: - )

3 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
49	全身性エリテマトーデス	1
51	全身性強皮症	1

告示番号	疾患名（ページ内リンク）	臨床試験数
226	間質性膀胱炎（ハンナ型）	1

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR-IOR-17012802	2017-09-26	2017-09-26	Synergy effects and health regulation effect of oxygen-ozonetherapy on systemic lupus erythematosus ...	Synergy effects and health regulation effect of oxygen-ozonetherapy on systemic lupus erythematosus ...	systemic lupus erythematosus (SLE)	the Controled Group:basic oral therapy;the Treated Group:basic oral therapy + Autologous blood trans ...	Guangdong Provincial Hospital of Chinese Medicine	NULL	Recruiting	18	65	Both	the Controled Group:30;the Treated Group:30;		China

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03742466 (ClinicalTrials.gov)	November 10, 2018	10/11/2018	Local Injection of OzoneVersus Methylprednisolone Acetate in Carpal Tunnel Syndrome of Scleroderma P ...	Local Injection of OzoneVersus Methylprednisolone Acetate in Carpal Tunnel Syndrome of Scleroderma P ...	Carpal Tunnel Syndrome;Chronic Pain;Scleroderma	Drug: Ozone;Drug: methylprednisolone acetate	Assiut University	NULL	Completed	20 Years	60 Years	All	50	N/A	Egypt

臨床試験数 : 145 / 薬物数 : 156 - (DrugBank : 51) / 標的遺伝子数 : 64 - 標的パスウェイ数 : 146

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04789135 (ClinicalTrials.gov)	March 20, 2020	1/3/2021	Evaluation of Response to Use of Intravesical OzoneGas in Interstitial Cystitis /Bladder Pain Syndro ...	Evaluation of Response to Use of Intravesical OzoneGas in Interstitial Cystitis/Bladder Pain Syndrom ...	Interstitial Cystitis, Chronic;Bladder Pain Syndrome	Drug: Ozone	Anhembi Morumbi University	NULL	Active, not recruiting	N/A	N/A	Female	50	Phase 2	Brazil